ContextVision Investor Relations Material
Latest events
Q1 2025
ContextVision
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from ContextVision
Access all reports
ContextVision's solutions include GOPiCE, a pre-processing technology for medical images that reduces the noise in images and enhances the details in images; ANDROS CLINICiMAGE, an image analysis solution for prostate cancer; GENESISiMAGE, a visualization and image analysis software solution for gynecology exams; ANDROS iQA that supports physicians with visual information during quality control in mammography; BABYLON iQI that enables automatic detection of 7 different parameters of breast density in mammogram cases; and INFINITY FOCUS CONDENSER, an imaging analysis technology. The company was formerly known as Xenex AB. ContextVision AB was founded in 1983 and is headquartered in Stockholm, Sweden.
Latest articles
)
David A. Ricks: Eli Lilly's Chairman and CEO
David Ricks built a decades-long career at Eli Lilly, now leading the giant company through a defining moment in its long pharmaceutical history.
3 Jul 2025
)
D. E. Shaw & Co: Inside the Quiet Giant of Quant Finance
A deep dive into D. E. Shaw's evolution from a $28M quant startup to a $65B hedge fund giant, built on research, computing, and quiet consistency.
2 Jul 2025
)
Pershing Square Capital Management: Conviction, Reinvention, and Contrarian Investing
Pershing Square Capital Management has grown into a top-tier hedge fund through reinvention, conviction, and focus on long-term value creation.
2 Jul 2025
Ticker symbol
CONTX
Country
🇳🇴 Norway